» Articles » PMID: 24839483

Clinico-pathological Analysis of Renal Cell Carcinoma Demonstrates Decreasing Tumour Grade over a 17-year Period

Overview
Specialty Urology
Date 2014 May 20
PMID 24839483
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Renal cell carcinoma (RCC) represents about 3% of adult malignancies in Ireland. Worldwide there is a reported increasing incidence and recent studies report a stage migration towards smaller tumours. We assess the clinico-pathological features and survival of patients with RCC in a surgically treated cohort.

Methods: A retrospective analysis of all nephrectomies carried out between 1995 and 2012 was carried out in an Irish tertiary referral university hospital. Data recorded included patient demographics, size of tumour, tumour-node-metastasis (TNM) classification, operative details and final pathology. The data were divided into 3 equal consecutive time periods for comparison purposes: Group 1 (1995-2000), Group 2 (2001-2006) and Group 3 (2007-2012). Survival data were verified with the National Cancer Registry of Ireland.

Results: In total, 507 patients underwent nephrectomies in the study period. The median tumour size was 5.8 cm (range: 1.2-20 cm) and there was no statistical reduction in size observed over time (p = 0.477). A total of 142 (28%) RCCs were classified as pT1a, 111 (21.9%) were pT1b, 67 (13.2%) were pT2, 103 (20.3%) were pT3a, 75 (14.8%) were pT3b and 9 (1.8%) were pT4. There was no statistical T-stage migration observed (p = 0.213). There was a significant grade reduction over time (p = 0.017). There was significant differences noted in overall survival between the T-stages (p < 0.001), nuclear grades (p < 0.001) and histological subtypes (p = 0.022).

Conclusion: There was a rising incidence in the number of nephrectomies over the study period. Despite previous reports, a stage migration was not evident; however, a grade reduction was apparent in this Irish surgical series. We can demonstrate that tumour stage, nuclear grade and histological subtype are significant prognosticators of relative survival in RCC.

Citing Articles

CT and MRI findings of cystic renal cell carcinoma: comparison with cystic collecting duct carcinoma.

Zhu Q, Ling J, Ye J, Zhu W, Wu J, Chen W Cancer Imaging. 2021; 21(1):52.

PMID: 34493335 PMC: 8422719. DOI: 10.1186/s40644-021-00419-1.


Radical nephrectomy with resection of vena cava thrombus using extracorporeal circulation and deep hypothermic circulatory arrest.

Nason G, Ajib K, Tan G, Woon D, Christakis G, Nam R Can Urol Assoc J. 2020; 15(4):E199-E204.

PMID: 33007182 PMC: 8021430. DOI: 10.5489/cuaj.6736.


Platelet to white blood cell ratio predicts 30-day postoperative infectious complications in patients undergoing radical nephrectomy for renal malignancy.

Garbens A, Wallis C, Bjarnason G, Kulkarni G, Nathens A, Nam R Can Urol Assoc J. 2017; 11(11):E414-E420.

PMID: 29072562 PMC: 5698019. DOI: 10.5489/cuaj.4478.


Solidifying prognosis after surgery for renal cell carcinoma.

Leveridge M Can Urol Assoc J. 2014; 8(3-4):133-4.

PMID: 24839484 PMC: 4001636. DOI: 10.5489/cuaj.2074.

References
1.
Frank I, Blute M, Leibovich B, Cheville J, Lohse C, Zincke H . Independent validation of the 2002 American Joint Committee on cancer primary tumor classification for renal cell carcinoma using a large, single institution cohort. J Urol. 2005; 173(6):1889-92. DOI: 10.1097/01.ju.0000158043.94525.d6. View

2.
Sorbellini M, Kattan M, Snyder M, Reuter V, Motzer R, Goetzl M . A postoperative prognostic nomogram predicting recurrence for patients with conventional clear cell renal cell carcinoma. J Urol. 2004; 173(1):48-51. DOI: 10.1097/01.ju.0000148261.19532.2c. View

3.
Ishikawa I, Honda R, Yamada Y, Kakuma T . Renal cell carcinoma detected by screening shows better patient survival than that detected following symptoms in dialysis patients. Ther Apher Dial. 2005; 8(6):468-73. DOI: 10.1111/j.1774-9987.2004.00192.x. View

4.
Lyrdal D, Aldenborg F, Holmberg E, Peeker R, Lundstam S . Kidney cancer in Sweden: a decrease in incidence and tumour stage, 1979 - 2001. Scand J Urol. 2012; 47(4):302-10. DOI: 10.3109/00365599.2012.732608. View

5.
Zucchi A, Novara G, Costantini E, Antonelli A, Carini M, Carmignani G . Prognostic factors in a large multi-institutional series of papillary renal cell carcinoma. BJU Int. 2011; 109(8):1140-6. DOI: 10.1111/j.1464-410X.2011.10517.x. View